Cannabiglendol-C3

Posted: September 28, 2020
Updated: December 25, 2023

What is Cannabiglendol-C3?

Cannabiglendol-C3 was one of the first cannabinoids ever discovered in the cannabis plant. Although the compound was identified by Turner in 1981, there is still little to no information concerning its therapeutic benefits and possible interaction with other cannabinoids.

Cannabiglendol-C3 was isolated from the leaves and small stems of an Indian variant of cannabis sativa grown in Mississippi.

A derivative of cannabinol (CBD), with an IUPAC name of 8-OH-sisohexaliydrocannabinol, cannabiglendol is considered a hydroxyl-derivative of the CBD group. Since cannabiglendol-C3 shares some similarities with cannabinol (CBN), it’s conceivable the compounds may also interact with cannabinoid receptors and mimic the same therapeutic benefits.

CBN is a mildly psychoactive member of the cannabinoid family and occurs in trace amounts in cannabis plant. It is more highly concentrated in older cannabis plants and is also formed as a metabolite of tetrahydrocannabinol (THC).

Although CBN has been successfully extracted in trace quantities from the cannabis plant, there is debate on whether it should be regarded as a naturally occurring or synthetic cannabinoid.

At this time we are unsure of the connection, if any, between CBN and cannabiglendol-C3 other than sharing the same parent chain in which cannabiglendol-3 is a hydroxyl derivative.

How does Cannabiglendol C3 work?

As stated earlier, cannabiglendol-C3 is an uncategorized (miscellaneous) cannabinoid. Information concerning its interaction with cannabinoid receptors is still unknown.

Related: What is CBN?

Since it has some relationship with CBN, it is believed that cannabiglendol may be slightly psychoactive. That said, it may exhibit a completely different interaction with cannabinoid receptors once tested.

Since the compound is only present in minute quantities, carrying out a detailed study to understand its level of activity and therapeutic benefits may be regarded as too costly.

It is worth considering that cannabiglendol was only isolated from the leaves and stems of Indian variants of cannabis sativa grown in Mississippi. There is little evidence of its presence in other cannabis plants around the world.

Related: How Does CBD Work

For now, we are optimistic scientists may pick up interest in the cannabinoid and carry out a detailed research on its activity and potential therapeutic benefits.

Potential Therapeutic Benefits

There is little to no information about the potential benefits of Cannabiglendol in treating diseases or providing therapeutic benefits to animals. Since the compound shares some characteristics with CBN, it is possible the two compounds may exhibit a similar interaction with the cannabinoid receptors.

Related: CBD vs CBN

Interesting Facts

Cannabiglendol-C3 has a molecular weight of 304.42g/mol
It is often regarded as a hydroxyl cannabinoid
It was extracted from the stems and leaves of Indian variants of cannabis sativa plants grown in Mississippi.
It shares some structural similarities with the mildly psychoactive Cannabinol (CBN).
Cannabiglendol-C3 is also known as 8-OH-sisohexaliydrocannabinol

References

Turner, C. E., Mole, M. L., Hanus, L., & Elsohly, H. N. (1981). Constituents of Cannabis sativa. XIX. Isolation and Structure Elucidation of Cannabiglendol, A Novel Cannabinoid From an Indian Variant. Journal of Natural Products, 44(1), 27–33.

Back to List of Cannabinoids

Search our website for more information on CBD:

Commitment to Trusted Information on CBD

When it comes to understanding both the science and benefits of cannabidiol (CBD), it is extremely important that you can trust the source of your information. This is exactly why our team at New Phase Blends includes experts in the field of cannabinoid research and development, including frequent correspondence with certified medical professionals and PhDs in relevant fields via studies, research, and additional peer reviewed pieces of information. All information published is reviewed and checked for accuracy. We pride ourselves on staying up-to-date with the latest scientific research and clinical studies related to not only CBD, but also its effects on the human body.

Our website also includes an About Us page, where you can learn more about our team, mission, and commitment to providing accurate, reliable information about CBD. Users can access this from the header menu at the top of the screen. Additionally, all of our products are third-party lab tested for quality and purity, and we make the results of these tests easily accessible to our customers.

User Experience Strengthened Through The Use of AI Content

Some articles you read may contain content created by the use of AI tools. This content is always edited by a human. We fact check any AI content, and ensure the information produced is accurate, up to date, and relevant to the article it may be contained in. All content is verified against peer reviewed data on CBD written by PhD’s and respective experts in their field of medical science.

Our goal in using AI content is to increase the user experience by increasing content production, and quality. This results in more information becoming available to the reader more frequently.

About the Author - CBD Expert Dale Hewett

Dale Hewett

Dale Hewett is the owner and founder of New Phase Blends. He discovered his passion for CBD use after suffering from injuries sustained while on Active Duty in the US Army. His number one priority is introducing the same CBD products that he himself uses for relief to others who can benefit from them.

Dale holds a Master Degree of Science, and is the inventor of the popular, CBD-based sleep aid known as ‘Sleep.’ He’s given multiple lectures on CBD to institutions such as Cornell’s MBA student program, and Wharton’s School of Business.